Novartis donates Rs 16 Crore gene therapy to 23 month old Spinal Muscular Atrophy Type 1 patient Roshni Dhar9 Aug 2022 6:00 PM ISTA 23-month-old baby with Spinal Muscular Atrophy (SMA) Type 1, received a new lease of life with Swiss drugmaker Novartis coming forward to donate...
Health Bulletin 9/ August/ 2022 Roshni Dhar9 Aug 2022 5:27 PM ISTHere are the Top Health stories for the day:Telangana baby with rare genetic disease administered Rs 16 crore drugA 23-month-old baby with Spinal...
Novartis donates Rs 16 crore drug to 23 month old Spinal Muscular Atrophy Type 1 patient MD Bureau8 Aug 2022 4:16 PM ISTAccording to Praveen, they had registered their daughter under Managed Access Programme of Novartis and they received the information that the company...
CDSCO panel rejects Novartis Phase III CT protocol for Lanalumab Rahul Verma30 July 2022 6:33 PM ISTCiting that the clinical trial protocol missed some inclusion/exclusion criteria, the Subject Expert Committee (SEC) functional under Central Drug...
Novartis Phase III CT protocol for Lanalumab Rejected by CDSCO Panel Dr. Divya Colin29 July 2022 6:00 PM ISTNew Delhi: Citing that the clinical trial protocol missed some inclusion/exclusion criteria, the Subject Expert Committee (SEC) functional under...
CDSCO panel nod to Novartis Ruxolitinib for acute and chronic graft versus host disease Rahul Verma24 July 2022 2:15 PM ISTIn response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert Committee (SEC)...
Novartis Ruxolitinib Gets CDSCO Panel Okay for Acute and Chronic Graft Versus Host Disease Dr. Divya Colin22 July 2022 6:00 PM ISTNew Delhi: In response to the pharma major Novartis proposal for additional indication of Ruxolitinib Tablets 5/10/15/20 mg, the Subject Expert...
Novartis no longer expects earnings decline at under-review Sandoz unit Ruchika Sharma19 July 2022 12:41 PM ISTNew Delhi: Swiss drugmaker Novartis said earnings at its Sandoz unit, the maker of cheap generic drugs that might be put up for sale, would...
Novartis leaning toward spinoff of USD 25 billion generics arm: Bloomberg Ruchika Sharma3 July 2022 12:30 PM ISTNew Delhi: Novartis AG is leaning toward a spinoff of its generic-drug unit, as a challenging environment for leveraged buyouts makes a potential sale...
Biocon engages law firm for governance review after CBI arrests Ruchika Sharma1 July 2022 2:30 PM ISTNew Delhi: Drugmaker Biocon Ltd. has engaged an external law firm to do a comprehensive review of its governance processes involving consultants and...
Novartis division Sandoz inaugurates facility in Maharashtra for oral cancer medicines Ruchika Sharma1 July 2022 1:30 PM ISTThe plant, which is spread over 32,000 square metres, would cater to the export markets, it added.
Novartis to sack up to 8000 jobs worldwide Ruchika Sharma29 Jun 2022 2:53 PM ISTNovartis said the new structure would be implemented over the next months.
